On the basis of these results, Paramasivan et al. [77] suggested targeting of m6A levels through methyltransferase (METTL3) and demethylase (FTO) enzyme as potential therapeutic strategy for hypertension. The gene discussed is FTO; the disease is hypertensive disorder.